We are pleased to initiate coverage on the German Clinical stage biopharmaceutical company CureVac. Find out our outlook, recommendations and valuations below.
Remember the good-old days when we were naïve enough to think that the next war (if ever a...
2022 confirmed the recovery of the travel industry, post Covid. How is Amadeus IT Group fairing wit...
Subscribe to our blog
The beauty giant published an encouraging set of FY22 results, with both the top line and the profita...
What is SFDR?The Sustainable Finance Disclosure Regulation (SFDR) imposes mandatory ESG di...
We are excited to initiate coverage for Siltronic. Siltronic covers the second major step in the electro...